Advanced search×

Hyperphosphatemia and phosphate binders.

Jason J JJ Schucker and Kristina E KE Ward

Am J Health Syst Pharm 62(22):2355-61 (2005) PMID 16278327

The pathophysiology of hyperphosphatemia associated with end-stage renal disease and treatment with phosphate binders are discussed.

Version: za2963e q8zad q8zb5 q8zcc q8zd3 q8ze1 q8zfa q8zg6

Similar articles you may find interesting…

  1. Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial.
    Stuart M SM Sprague, Hanna H Abboud, ... William W Finn

    Clin J Am Soc Nephrol 4(1):178-85 (2009) PMID 19056618

    Because <1% of phosphorus is in the extracellular fluid, serum measurements may not accurately reflect total body burden in patients with CKD stages 3 and 4. However, lanthanum carbonate is an effective phosphate binder in this patient population, with a safety profile and tolerability similar to th...
  2. [Role of diet in the management of osteodystrophy during progressive renal insufficiency].
    I I Martínez, R R Saracho, ... J J Montenegro

    Nefrologia (2003) PMID 12778856

    We propose a treatment strategy which adapts to the different degrees of renal failure....
  3. Pathophysiology of septic encephalopathy--an unsolved puzzle.
    Flierl MA, Rittirsch D, ... Stahel PF

    Audio, Transactions of the IRE Professional ... 14(3):165 (2010) PMID 20565858

    We are far from fully understanding the neuropathology that develops as a secondary remote organ injury as a consequence of sepsis. However, recent studies suggest that bacterial proteins may readily cross the functional BBB and trigger an inflammatory response in the subarachnoid space, in absence...
    View PDF